LLumicell Diagnostics develops intraoperative imaging for cancer surgery. Its core product, the Lumicell Direct Visualization System (DVS), uses a hardware imaging platform paired with a proprietary fluorescent imaging agent to illuminate cancer cells in real time during surgery. The system helps surgeons identify and remove malignant tissue that is not visible to the eye, aiming to reduce positive margins and the need for repeat surgeries. The company differentiates itself by delivering an integrated hardware-and-agent solution for fluorescence-guided, real-time visualization in the operating room, with an initial focus on breast cancer and plans to expand to other cancer types, targeting commercialization at scale to improve surgical outcomes.
Work here?Claim your company
We're working on gathering enough insights on this company, check back soon!
Industries
Company Size
51-200
Company Stage
Grant
Total Funding
$83.9M
Headquarters
Waltham, MA
Founded
2009
See people who can refer or advise you
Total Funding
$83.9M
Meets
Industry Average
Funded Over
10 Rounds
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
We're working on gathering enough insights on this company, check back soon!
Industries
Company Size
51-200
Company Stage
Grant
Total Funding
$83.9M
Headquarters
Waltham, MA
Founded
2009
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs